Microglial circadian clock regulation of microglial structural complexity, dendritic spine density and inflammatory response

Neurochem Int. 2021 Jan:142:104905. doi: 10.1016/j.neuint.2020.104905. Epub 2020 Nov 18.

Abstract

Cortical microglia exhibit a ramified shape during sleep, while they have a hyper-ramified shape during wakefulness, which is characterized by their longer processes with increased branching points. The microglial molecular circadian clock regulates expressions of both cathepsin S (CatS) and P2Y12 receptors in the brain with a peak at zeitgeber time 14 (2 h after beginning of the dark phase). We postulated that these two microglia-specific molecules contribute to diurnal alterations of microglial shapes and neuronal activities in the cerebral cortex. During wakefulness, CatS secreted from cortical microglia may be involved in P2Y12 receptor-dependent process extension. Secreted CatS subsequently degrades the perineuronal nets, initiating the downscaling of both spine density and synaptic strength of cortical neurons toward the beginning of sleep. The downscaling of both spine density and synaptic strength of cortical neurons during sleep could improve signal-to-noise, which would benefit memory consolidation, or allow for new learning to occur during subsequent waking. Furthermore, disruption of CatS induces the sleep disturbance and impaired social interaction in mice. Moreover, the microglial clock system disruption may also play a role in the early pathogenesis of Alzheimer's disease. The reduced expression of BMAL1 in cortical microglia caused by oligomeric amyloid β may induce the increased presence of inflammatory phenotype through a reduction in RORα, which in turn reduced IκBα and enhanced NF-κB activation. These observations suggest that the microglial clock system disruption contribute to pathogeneses of sleep disturbance, impaired social interaction and cognitive impairment. Therefore, the growing understanding of the microglial circadian molecular clock might aid in the development of novel pharmacological interventions against both neuropsychiatric and neurodegenerative disorders.

Keywords: Alzheimer's disease; Cathepsin S; Clock genes; Microglia; Neuroinflammation; P2Y12 receptors.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Cerebral Cortex / metabolism
  • Cerebral Cortex / pathology
  • Circadian Clocks / physiology*
  • Dendritic Spines / metabolism*
  • Dendritic Spines / pathology
  • Humans
  • Inflammation Mediators / metabolism*
  • Microglia / metabolism*
  • Microglia / pathology
  • Receptors, Purinergic P2Y12 / metabolism
  • Wakefulness / physiology

Substances

  • Inflammation Mediators
  • P2RY12 protein, human
  • Receptors, Purinergic P2Y12